Results 251 to 260 of about 92,484 (303)

Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectives. [PDF]

Front Pharmacol
Tamehri Zadeh SS, Toth PP, Banach M.
europepmc   +1 more source

A Novel ApoB/ApoA1 Ratio-Integrated Nomogram to Predict Cardiogenic Shock After Acute Myocardial Infarction. [PDF]

Rev Cardiovasc Med
Zhang X, Chen L, Tian N, Qin H, Bao L.
europepmc   +1 more source

High Density Lipoprotein Assessment Revisited: A Review of Foundational Understanding and Recent Developments in Function, Particle Size, and Cardiometabolic Impact. [PDF]

Curr Atheroscler Rep
Sherly A A, Mysore Srikantiah R, Rohatgi A, Hegde A, H S, S A.   +5 more
europepmc   +1 more source

Plasma proteome is altered in a piglet model of fetal growth restriction. [PDF]

Sci Rep
Musco H, Lee A, Chand KK, Colditz PB, Wixey JA.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Apolipoprotein C-II Deficiency

1986
The lipolysis of chylomicrons and very low density lipoproteins is responsible for the delivery of energy in the form of fatty acids to adipose or muscle tissue. The fatty acids are transported in the form of triacylglycerols in these lipoproteins following their synthesis in the intestine or liver.
A. L. Catapano, A. Capurso
openaire   +3 more sources

Apolipoprotein C-II deficiency associated with nonfunctional mutant forms of apolipoprotein C-II

Canadian Journal of Biochemistry and Cell Biology, 1984
Two previously unidentified apolipoproteins (apo) designated apo C-II-X and C-II-Y have been found in plasma of homozygotes and obligate heterozygotes of a family with apo C-II deficiency. Because the plasmas of homozygotes do not activate lipoprotein lipase, apo C-II-X and C-II-Y are apparently nonfunctional.
G F, Maguire, J A, Little, G, Kakis, W C, Breckenridge   +3 more
openaire   +2 more sources

A purification method for apolipoprotein A-I and A-II

Analytical Biochemistry, 1989
Apolipoproteins A-I and A-II were isolated from precipitates obtained by cold ethanol fractionation of human plasma. The starting material used in this report was precipitate B of the Kistler and Nitschmann method which corresponds approximately to fraction III of the Cohn and Oncley procedure.
Peitsch MC, Kress A, Lerch PG, Morgenthaler JJ, Isliker H, Heiniger HJ   +5 more
openaire   +3 more sources

Apolipoprotein A-II, HDL metabolism and atherosclerosis

Atherosclerosis, 2002
Apolipoprotein (Apo) A-I and apo A-II are the major apolipoproteins of HDL. It is clearly demonstrated that there are inverse relationships between HDL-cholesterol and apo A-I plasma levels and the risk of coronary heart disease (CHD) in the general population.
Anne, Tailleux, Patrick, Duriez, Jean-Charles, Fruchart, Véronique, Clavey   +3 more
openaire   +2 more sources

Metabolism of apolipoproteins A-I, A-II, and A-IV

1986
Publisher Summary Kinetic studies utilizing radioiodinated apolipoproteins have yielded important insights into lipoprotein metabolism. A major concern in these studies is that the tracer has identical kinetic behavior in vivo to native lipoproteins.
E J, Schaefer, J M, Ordovas
openaire   +2 more sources

Apolipoprotein A-II modulates HDL remodeling in plasma

Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
Native and reduced-carboxamidomethylated (RCM) HDL3 are incubated with a lipoprotein-depleted plasma fraction in the presence of triacylglycerol-rich particles isolated from Intralipid. Unmodified HDL3 are mainly converted into large HDL2b particles (diameter: 9.84 +/- 0.15 nm); RCM-HDL3 are transformed into both large HDL2b (9.76 +/- 0.10 nm) and ...
L. CALABRESI, C. BANFI, C. SIRTORI, G. FRANCESCHINI   +3 more
openaire   +2 more sources